InnoGenomics Technologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $370K

  • Investors
  • 4

InnoGenomics Technologies General Information

Description

Developer of genetic testing and forensic analysis technologies in New Orleans, Louisiana. The company offers DNA quantification kits, genetic profiling systems, differential DNA extraction technology, STR genotyping, gene expression assays, and custom laboratory testing services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • 2000 Lakeshore Drive
  • Suite 5016
  • New Orleans, LA 70148
  • United States
+1 (504)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Services
Corporate Office
  • 2000 Lakeshore Drive
  • Suite 5016
  • New Orleans, LA 70148
  • United States
+1 (504)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InnoGenomics Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - General 13-Aug-2018 $370K Completed Generating Revenue
7. Grant 31-Dec-2017 Completed Generating Revenue
6. Debt - General 21-Sep-2017 Completed Generating Revenue
5. Grant 31-Dec-2015 Completed Generating Revenue
4. Grant 18-Nov-2015 Completed Generating Revenue
3. Debt - General 29-Jun-2015 Completed Generating Revenue
2. Grant 24-Mar-2015 $80K Completed Startup
1. Grant 01-Jan-2012 $650K Completed Startup
To view InnoGenomics Technologies’s complete valuation and funding history, request access »

InnoGenomics Technologies Patents

InnoGenomics Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10415031-B2 Method, apparatus and kit for human identification using polymer filter means for separation of sperm cells from biological samples that include other cell types Active 04-Feb-2015
US-20160222375-A1 Method, apparatus and kit for human identification using polymer filter means for separation of sperm cells from biological samples that include other cell types Active 04-Feb-2015
WO-2016109604-A2 Multiplexed assay for quantitating and assessing integrity of cell-free dna in biological fluids for cancer diagnosis, prognosis, and surveillance Inactive 29-Dec-2014
WO-2016109604-A3 Multiplexed assay for quantitating and assessing integrity of cell-free dna in biological fluids for cancer diagnosis, prognosis, and surveillance Inactive 29-Dec-2014 C12Q1/686

InnoGenomics Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnoGenomics Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
The United States Department of Justice Government
New Orleans BioInnovation Center Accelerator/Incubator Minority
Jefferson Parish Economic Development Commission Government Minority
US National Science Foundation Accelerator/Incubator
To view InnoGenomics Technologies’s complete investors history, request access »

InnoGenomics Technologies FAQs

  • When was InnoGenomics Technologies founded?

    InnoGenomics Technologies was founded in 2010.

  • Where is InnoGenomics Technologies headquartered?

    InnoGenomics Technologies is headquartered in New Orleans, LA.

  • What is the size of InnoGenomics Technologies?

    InnoGenomics Technologies has 9 total employees.

  • What industry is InnoGenomics Technologies in?

    InnoGenomics Technologies’s primary industry is Diagnostic Equipment.

  • Is InnoGenomics Technologies a private or public company?

    InnoGenomics Technologies is a Private company.

  • What is InnoGenomics Technologies’s current revenue?

    The current revenue for InnoGenomics Technologies is .

  • How much funding has InnoGenomics Technologies raised over time?

    InnoGenomics Technologies has raised $745K.

  • Who are InnoGenomics Technologies’s investors?

    The United States Department of Justice, New Orleans BioInnovation Center, Jefferson Parish Economic Development Commission, and US National Science Foundation have invested in InnoGenomics Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process